Mettler-Toledo International, I
MTD Large CapHealthcare · Diagnostics & Research
Updated: Jun 14, 2026, 22:19 UTC
Price Chart
Key Metrics
Valuation Analysis
About the Company
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also p
Mettler-Toledo International, I Stock at a Glance
Mettler-Toledo International, I (MTD) is currently trading at $1,131.49 with a market capitalization of $22.9B. The trailing P/E ratio stands at 26.6x, with a forward P/E of 22.07x. The 52-week range spans from $1,023.05 to $1,525.17; the current price is 25.8% below the yearly high. Year-over-year revenue growth stands at +7.2%. The net profit margin stands at 21.4%.
💰 Dividend
Mettler-Toledo International, I currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Analyst Rating
12 analysts rate Mettler-Toledo International, I (MTD) on consensus: Buy. The average price target is $1,327.83, implying +17.35% from the current price. Analyst price targets range from $1,194.00 to $1,550.00.
Mettler-Toledo International, I: The Investment Case in Detail
Mettler-Toledo International, I (MTD) operates in the Healthcare — specifically Diagnostics & Research — and is headquartered in Switzerland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
The Bull Case
The combination of a 59.19% gross margin and 23.29% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Free cash flow is positive and net margins stand at 21.4%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions. Wall Street consensus sits at Buy with an average price target implying roughly 17.35% upside from current levels — analyst sentiment is firmly constructive.
What to Watch Next
- The forward P/E of 22.07x is meaningfully below the trailing 26.6x — analysts expect earnings to step up; the next earnings release is the test.
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
Investment Thesis: Strengths & Weaknesses
- Profitable with 21.4% net margin
- High gross margin of 59.19% — indicates pricing power
- Analyst consensus: Buy
- Positive free cash flow
No significant red flags in current metrics.
Technical Snapshot
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Risk Profile
The data points to market-like volatility.
Trading Data
Related Stocks in the Same Sector
More Healthcare stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Mettler-Toledo International, I?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
